As the Exome Aggregation Consortium (Exac) published findings from their deep dive into the genetic well Wednesday, another set of scientists published a cautionary tale illustrating the sort of clinical problem that Exac's Exome Sequencing Project (ESP) can address. (See story in this issue.)